30 Day Trial
BARE BONES logo

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Episurf Continues to Gather Clinical Evidence During Early Commercialization Efforts -

Episurf reports 3Q19 revenue of SEK 1.1MM (USD $0.1MM), +13.4% vs. 3Q18.

  • Gross order intake for the quarter increased 21% year over year, and 51% for the nine-month period ending September 30, 2019
  • Per leadership, around 80% of Episealer orders originate in Germany
  • Orders for the Episealer knee implant increased 60% vs. prior year, with 56 orders in the quarter
  • Within the quarter, Episurf achieved a milestone of 600 implantations to date and gained approval to sell the Episealer knee implant in Italy
  • The company experienced increased costs in the quarter due to work on its Investigational Device Exemption study in the U.S., amounting to SEK 5MM (USD $.5MM)
  • Episurf expects CE Mark approval for the Episealer Talus ankle implant before the end of 2019
  • In July 2019, the company entered into a Letter of Intent with a US-based orthopedic company for use of its AI-based Epioscopy imaging technology and now has a trial agreement in place to jointly explore opportunities for further commercial collaboration
  • ORTHOWORLD projects Episurf 2019 full year revenue of SEK 4.8MM (USD $.5MM), +17% vs. 2018

 

“We are only scratching the surface of our addressable market, and we look forward to further market penetration. The key to achieving this is to have more clinical evidence published, which will lead to an improved operating environment, meaning that factors such as hospital approvals, surgeon confidence, reimbursement and patient awareness are improved.” – Episurf CEO Pål Ryfors

 

ORTHOWORLD estimates segment sales and growth on an as-reported basis ($MM).

  3Q19 3Q18 $ Chg % Chg
Joint Replacement, Knees $0.1 $0.1 $0.0 13.4%
  9mo 19 9mo 18 $ Chg % Chg
Joint Replacement, Knees $0.4 $0.3 $0.1 20.8%

 

Source: Episurf

Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.